Müller, Thomas <br/><br/>
The Molecular and Cellular Basis for Parkinson's Disease 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>microRNAs||disease-modifying effects||SH-SY5Y||inpatient treatment||sphingolipids||neurodegeneration||magnetic resonance spectroscopy||MO3.13||schizophrenia||epigenetics||long-chain acylcarnitine||molecular mimicry||curli||multimodal complex treatment||chlorogenic acid||glycerophospholipids||caffeic acid||lipoproteins||myenteric plexus||neurometabolites||HOG||immature oligodendrocyte||autophagy||oligodendrocyte||hypochlorite||alpha-synuclein||microbiome||glucocerebrosidase||Lewy Body Dementia||brain iron||mesenchymal stem cells||fatty acid ?-oxidation||GABA||enteric glial cell||gut-brain axis||microbiota||REM sleep behavior disorders||redox cycling||magnetic resonance imaging||differentiation||?-synuclein-mediated pathology||Parkinson disease||Gaucher’s disease||metallothionein||[123I]FP-CIT-SPECT||dopaminergic neuron||mature oligodendrocyte||glycerolipids||spectroscopy||neuroinflammation||exosomes||immunotherapy||DNA methylation||sterol lipids||nigral cells||cell line||cysteinyl-dopamine||myelin||parkinsonisms||multiple sclerosis||rotenone||brain||fatty acyls||Krabbe’s disease||neuroprotection||DAT||motor dysfunction||secretome||multiprofessional therapy||Parkinson’s disease||oxidative stress||alpha-Synuclein